Unknown OBSERVATIONAL NCT03676881

Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease

Sponsor: Bruyère Health Research Institute.

Conditions Alzheimer Disease Dementia Mild Cognitive Impairment Neuropathology

Interventions Computerized cognitive battery: Cognigram (CG) The NeuroCatch™ Platform (NCP)

Updated 7 times since 2018 Last updated: Jan 13, 2020 Started: Sep 4, 2018 Primary completion: Dec 31, 2021 Completion: Dec 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Alzheimer Disease and Dementia and is currently ongoing. Bruyère Health Research Institute. leads this study, which shows 7 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Jul 2025 — Present [monthly]

Unknown
Sep 2024 — Jul 2025 [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Mar 2022 — Jul 2024 [monthly]

Unknown Status

Status: Active Not Recruiting → Unknown Status
Jan 2021 — Mar 2022 [monthly]

Active Not Recruiting

▶ Show 2 earlier versions

Feb 2020 — Jan 2021 [monthly]

Active Not Recruiting

Status: Recruiting → Active Not Recruiting
Oct 2018 — Feb 2020 [monthly]

Recruiting

First recorded

Sep 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bruyère Health Research Institute.

Data source: Bruyère Health Research Institute.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ottawa, Canada